CONTINUUS Pharmaceuticals enjoys successful 2016, looking forward to 2017

2016 marked a very successful year for CONTINUUS Pharmaceuticals.  The team was able to advance its innovative technology platform through work done with the National Science Foundation, as well as projects with commercial partners.  As a result, CONTINUUS was able to successfully secure follow-on projects as well as a 3-year $4.4 M contract with the US FDA to develop a science and risk-approach on how drug quality can be monitored and improved through integrated continuous manufacturing (ICM).  The company is looking for continued success in 2017.